Stock listing
Coegin Pharma Ab
Selected listing: A3EJC5 · LS · EUR · DE
Coegin Pharma Ab (Lang & Schwarz: A3EJC5), Health Technology. Latest release May 21, 2026: COEGIN: First commercial revenues achieved, portfolio expanded…
- Ticker
- Lang & Schwarz: A3EJC5
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Coegin Pharma Ab
COEGIN: First commercial revenues achieved, portfolio expanded, and liquidity strengthened via share issue
May 21, 2026
COEGIN: First commercial revenues achieved and liquidity strengthened, with expansion planned for 2026
February 26, 2026
COEGIN: Shifted to commercial operations with first Follicopeptide orders and improved financials
November 20, 2025
COEGIN: On track for hair growth product launch, costs cut 80%, and cash runway secured into Q2 2026
August 21, 2025
COEGIN: Follicopeptide launch on track, with improved Q1 results and strong market positioning
May 22, 2025
Research Coegin Pharma Ab
Alternate listings
COEGIN:NGM
SE · SEK
Alternate listing for Coegin Pharma Ab; the primary context on this page is A3EJC5:LS.
7Z6:SWB
DE · EUR
Alternate listing for Coegin Pharma Ab; the primary context on this page is A3EJC5:LS.
7Z6:FWB
DE · EUR
Alternate listing for Coegin Pharma Ab; the primary context on this page is A3EJC5:LS.
A3EJC5:LSX
DE · EUR
Alternate listing for Coegin Pharma Ab; the primary context on this page is A3EJC5:LS.